| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_653c418e41edbb4e1ce8bc5e53e70cec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed700c7d6b79390f9bf7cb31a034c259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93683ae9d72a95385de56ab13f91ef80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0618168372ef1c083ea2a0aa0d63412f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4359bf77fe4393a4142a0f176e445bd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45f7eff4813cb70958dcf1e7de15a477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a3a8e8815efcc46c5280c815be023d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1209ed6ffbc8d4f754ade64758e8a1c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b1cab67c639002abbe416db733e0c7c |
| publicationDate |
2019-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110229896-A |
| titleOfInvention |
Application of STEAP1 in the diagnosis, treatment and prognosis of ovarian cancer |
| abstract |
The present invention provides the application of STEAP1 in the diagnosis, treatment and prognosis of ovarian cancer. The present invention has found through research that STEAP1 plays an oncogene role in ovarian cancer, and the high expression of STEAP1 is positively correlated with the malignant phenotype of ovarian cancer and the poor prognosis of patients. Related; STEAP1 can promote the proliferation and inhibit the apoptosis of ovarian cancer cells. STEAP1 can promote the invasion and metastasis of ovarian cancer cells by promoting the process of EMT. It shows that STEAP1 is an oncogene involved in the occurrence and development of ovarian cancer, it can be used as a biomarker and therapeutic target of ovarian cancer, and has good practical application value. |
| priorityDate |
2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |